In today’s ACT Brief, we examine how AI and functional service partners are reshaping global pharmacovigilance, look at new ...

The FDA has approved Novartis’ Itvisma (onasemnogene abeparvovec-brve) for the treatment of adolescents two years and older, teens, and adults living with spinal muscular atrophy (SMA) with a ...

Artificial intelligence (AI) seems to be everywhere, but what is its future in clinical research? Clinical research inherently involves humans. However, it also involves numerous administrative ...

A new global Tufts CSDD survey of 387 investigative site professionals reveals broad experience with digital and decentralized trial tools, growing site-driven technology investments, and strong ...

AI-enabled automation is rapidly moving into routine pharmacovigilance operations, streamlining case intake and processing, reducing longstanding adoption barriers, and driving new efficiencies as ...

How pharma–hospital partnerships can overcome operational, financial, and organizational barriers to build high-performing clinical trial programs that expand access, accelerate accrual, and ...

Explore methods to evaluate recruitment performance across multiple platforms, including engagement tracking, conversion ...

Understand the regulatory and policy considerations for running clinical trial recruitment campaigns on nontraditional or ...

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical ...

Learn how demographic and behavioral insights inform platform-specific messaging, creative formats, and call-to-action ...

How sponsors can leverage technology to enhance, not hinder, site efficiency and usability Strategies to incorporate site ...

In today’s ACT Brief, we look at how Trialbee evaluates nontraditional digital platforms for patient recruitment, review new ...